The Director said
The U.S. Stock Intelligence Bureau will update the ARK transaction tracking every business day;
Mainly share the trading details of the day and analyze the recent performance of key stocks;
If ARK has a heavy sudden action, the director will also share it with everyone in time.
Sister Wood is not a god, but ARK is a high performer in the 2020 US fund; I hope that everyone can get a faster and more comprehensive investment dry goods >> at the US Stock Intelligence Agency
ARK Transaction Tracking
Edit: Jling
ARK had 42 trades on January 18, buying slightly more than selling (19). Since September last year, Wood Sister has successively reduced its holdings in Tesla shares, and Tesla is no longer the number one heavy stock of Ark's new generation Internet ETF (ARKW), accounting for 7.34%, becoming the second largest heavy stock after Coinbase (COIN) (7.8%).
As of Tuesday's close, Wood's Ark Innovation ETF (ARKK), which has fallen 18.7 percent so far this year, has fallen to a one-and-a-half-year low. Among them, 44 stocks were close to falling, with the worst two being 10x Genomics (TXG) and California Pacific Biosciences Corporation (PACB), which closed down 10.8% and the latter down 10.5%.
Source: Huasheng Information
The trading highlights of the day are as follows
Buy
1. Optimistic about the strategic cooperation between Shopify (SHOP) and JD .com (JD), spending about $10.55 million and copying nearly 18,000 shares of Shopify. On Tuesday, Shopify reached a strategic cooperation agreement with JD.com to accelerate business expansion in China. It is reported that the cooperation will allow retailers on Shopify to reach Chinese customers through JD.com and take advantage of JD.com's supply chain and logistics services. At the same time, Chinese merchants are also able to take advantage of Shopify's platform and market globally.
2. Intellia Therapeutics Inc (NTLA), a gene editing company that has copied the bottom, has about 152,000 shares and spent about $13.12 million. The stock fell more than 6% in the previous trading session. The company will discuss its roadmap for the future with investors at a JPMorgan chase meeting on Wednesday. Earlier, on Monday, Pfizer also announced a partnership with another gene editing company, Beam Therapeutics, involving $1.3 billion, and Wood Sister also spent about $4.71 million this time, bottoming out more than 70,000 shares of Beam Therapeutics.
3. Bottom out Silvergate Capital (SI) about 80,000 shares. The stock plunged more than 25 percent yesterday, and the company posted a lower-than-expected fourth-quarter 2021 earnings report: earnings per share of $0.66, less than analysts' estimates at Capital IQ surveys of $0.70; net interest income and noninterest income combined at $49.3 million, less than the survey's estimate of $53.7 million. During the day, Wade Bush will lower the company's price target to $165 (previously $ 175), but still maintain its "stronger than the broader market" rating.
Sell
1. Continue to sell about 380,000 shares of Snap (SNAP) and cash out about $13.55 million. The stock closed down more than 6 percent in the last session and is down more than 17 percent in the most recent week. Previously, investment banks Cowen and Wedbush lowered their target price, the former reducing the target price from $75 to $45, and the latter reducing the target price from $70 to $56
2. Sold about 465,000 shares of Takeda Pharmaceutical (TAK) (Takeda Pharmaceutical) and cashed out about $6.77 million. On Wednesday, the U.S. FDA rejected the company's drug DNL919, developed in collaboration with Denali, into clinical trials.
3. Sell about 23,000 shares and about 48,000 shares of Lockheed Martin (LMT) and Intercontinental Exchange (ICE) and cash out about $8.62 million and about $6.02 million.
ARK Last Investment Tracker: ARK Tracking | Pickup truck delivery delay Tesla to "fall out of favor"? 4 times to increase the position of this medical stock》
ARK Q2 Investment Report: "Dark Before Dawn or Naked in the Water?" ARK submits Q2 Answer Sheet
ARK First Quarter Investment Report: "ARK Fell to the Altar? The first quarter results tell you"
Introduction to the ARK Fund
ARK Investments is one of the most beautiful investment firms in the US market in the past year, and its founder and fund manager, Ms. Catherine Wood, has been hailed by countless investors as a tech stock goddess.
Image source: Public Network
Founded in 2014 by Cathie Wood, ARK focuses on investing in opportunities for "disruptive innovation", namely genetic technology, robotics, artificial intelligence, energy storage and blockchain technology. ARK's main ETF, ARKK, has outperformed the NASDAQ index by about 136% since its inception. In January this year, the ARK series of funds won more funds than traditional investment management giants BlackRock and State Street. At present, ARK adheres to the strategy of "buying growth mid-cap stocks and selling value large-cap stocks". The ARK Fund is the ninth largest ETF issuer in the world.
ARK's six active ETFs are
ARKQ (Autonomous Technology and Robotics): This fund invests in companies that develop business in autonomous transportation, robotics, automation, 3D printing, energy storage, space exploration, etc. The fund generally contains 30-50 stocks. The market capitalization at the end of March 2021 was about $3.34 billion.
ARKF (FinTech Innovation): The fund mainly invests in companies in trading innovation, blockchain technology, risk transformation, frictionless funding platform, customer-facing platform, and new intermediaries. The fund generally contains 30-50 stocks. The market capitalization at the end of March 2021 was about $3.88 billion.
ARKW (Next Generation Internet): This fund invests primarily in companies in cloud computing and cybersecurity, e-commerce, big data and artificial intelligence, IoT and mobile technologies, social platforms, blockchain and P2P technologies. The Fund generally contains 35-50 stocks. The market capitalization at the end of March 2021 was about $7.15 billion.
ARKG (Genomic Revolution): This fund invests primarily in companies in Crispr, gene editing technologies, targeted research therapies, bioinformatics, molecular diagnostics, stem cells, and agricultural biology. The fund generally contains 30-50 stocks. The market capitalization at the end of March 2021 was about $9.49 billion.
ARKK (Disruptive Innovation): This stock is a combination of four other active ETFs and the largest ETF by market capitalization. The Fund generally contains 35-55 stocks. The market capitalization at the end of March 2021 was about $21.02 billion.
ARKX (Space Exploration): The ETF was officially listed and traded on March 30, and mainly invests in orbital and suborbital space stocks, promotion technology stocks and space benefit stocks.